News und Analysen
![4 Oversold Large Cap Stocks Yielding High Dividends: https://www.marketbeat.com/logos/articles/med_20240313190843_4-oversold-large-cap-stocks-yielding-high-dividend.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDVVYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7b385179cb5f7c51dff538bc319cf9d2292640e5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240313190843_4-oversold-large-cap-stocks-yielding-high-dividend.jpg?locale=de)
4 Oversold Large Cap Stocks Yielding High Dividends
As the market continues its relentless ascent to new heights, propelled by the surging tech sector and hype surrounding AI, the murmurs of potential interest rate cuts by the Federal Reserve
![Big Investors Like What Comcast, Schwab, Alphabet Have to Offer: https://www.marketbeat.com/logos/articles/med_20240313185402_big-investors-like-what-comcast-schwab-alphabet-ha.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDlVYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8b0b7a8e89aa259defe1a597be40b5f2912119f0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240313185402_big-investors-like-what-comcast-schwab-alphabet-ha.jpg?locale=de)
Big Investors Like What Comcast, Schwab, Alphabet Have to Offer
Comcast Corp. (NASDAQ: CMCSA), Charles Schwab Corp. (NYSE: SCHW) and Alphabet Inc. (NASDAQ: GOOGL) are among institutional-quality large-cap stocks that are currently undervalued.
There are a few
![3 Small-Cap Leaders Poised for Significant Growth: https://www.marketbeat.com/logos/articles/med_20240312114211_3-small-cap-leaders-poised-for-significant-growth.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM3BUYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1e55d3b57876a6282080067b900e1c1ccd3f5405/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240312114211_3-small-cap-leaders-poised-for-significant-growth.jpg?locale=de)
3 Small-Cap Leaders Poised for Significant Growth
They may not be household names like Meta Platforms Inc. (NASDAQ: META) or investor favorites like Nvidia Corp. (NASDAQ: NVDA), but several small stocks, such as Ultra Clean Holdings, Inc.
![Eilt: Völlig neue Krebsbehandlung - Hautkrebs vollständig geheilt. Diesen Biotech Hot Stock jetzt kaufen nach 9.290% mit Novo-Nordisk ($NVO): https://www.irw-press.at/prcom/images/messages/2024/73926/AC_Vidac_130324.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHhUYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ce7c5152ac83a8a2ad9318acc6cb07e41bd1f877/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_Vidac_130324.001.png?locale=de)
Eilt: Völlig neue Krebsbehandlung - Hautkrebs vollständig geheilt. Diesen Biotech Hot Stock jetzt kaufen nach 9.290% mit Novo-Nordisk ($NVO)
Eilt: Völlig neue Krebsbehandlung - Hautkrebs vollständig geheilt. Diesen Biotech Hot Stock jetzt kaufen nach 9.290%
13.03.24 08:02
London (www.aktiencheck.de, Anzeige)
![Eilt: Studie für völlig neue Krebsbehandlung genehmigt. Neuer 797% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX): https://www.irw-press.at/prcom/images/messages/2024/73909/aktiencheck120324.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN0pSYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9ad1655e528f8b6baa5b4a7a39bf80531b6dbf7b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/aktiencheck120324.001.png?locale=de)
Eilt: Studie für völlig neue Krebsbehandlung genehmigt. Neuer 797% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX)
Eilt: Studie für völlig neue Krebsbehandlung genehmigt. Neuer 797% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX)
12.03.24
London (www.aktiencheck.de, Anzeige)
Link
![Another 20% Upside for Broadcom Stock: Analysts Say Buy the Dip: https://www.marketbeat.com/logos/articles/med_20240311080123_chart-avgo-3112024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL1JRYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--12880532264e7f034d6e59fff2a858c5e70c93a5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240311080123_chart-avgo-3112024ver001.png?locale=de)
Another 20% Upside for Broadcom Stock: Analysts Say Buy the Dip
The price action in Broadcom Inc. (NASDAQ: AVGO) began correcting after its FQ1 earnings release, and it may move lower, but this is a near-term phenomenon investors should embrace. Broadcom's
![Micron Stock: Why $100 per Share is Just the Start: https://www.marketbeat.com/logos/articles/med_20240308090853_micron-stock-why-100-per-share-is-just-the-start.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0JPYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b26c83d778411a78d98a00056552a96676dbf36d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240308090853_micron-stock-why-100-per-share-is-just-the-start.jpg?locale=de)
Micron Stock: Why $100 per Share is Just the Start
With shares of Micron Technology Inc. (NASDAQ: MU) trading up just over 1% in Friday's premarket session, it looks like the company will end the week on a high note.
Yesterday's 3.5% pop set the
![Apple Enters Oversold Territory, Time to Buy?: https://www.marketbeat.com/logos/articles/med_20240308083921_apple-enters-oversold-territory-time-to-buy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOTlPYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--192c168e103c35c92998f57c4a7cc82a275d024c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240308083921_apple-enters-oversold-territory-time-to-buy.jpg?locale=de)
Apple Enters Oversold Territory, Time to Buy?
Shares of the hardware and software consumer products giant Apple (NASDAQ: AAPL) have had a year to forget. The company’s stock has fallen over 12% year-to-date, bringing its one-year performance
![Microsoft Stock and The Case For A $500 Price Tag: https://www.marketbeat.com/logos/articles/med_20240308080209_microsoft-stock-and-the-case-for-a-500-price-tag.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0ZPYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6c585266b09b16be727298e4000d7dc7fad5ca99/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240308080209_microsoft-stock-and-the-case-for-a-500-price-tag.jpg?locale=de)
Microsoft Stock and The Case For A $500 Price Tag
With equities, in general, enjoying their best run in years, it will be no surprise to most that the tech stocks, in particular, are performing well. Much of this has to do with encouraging signs
![Eilt: Hautkrebs vollständig geheilt - Blockbuster gegen Hautkrebs. Neuer 797% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX): https://www.irw-press.at/prcom/images/messages/2024/73877/AC-080324.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMmxPYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0f1fba356be90663477837b8a5f96aee1ef9d8c1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-080324.001.png?locale=de)
Eilt: Hautkrebs vollständig geheilt - Blockbuster gegen Hautkrebs. Neuer 797% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX)
Eilt: Hautkrebs vollständig geheilt - Blockbuster gegen Hautkrebs. Neuer 797% Biotech Aktientip nach 15973% mit BioNTech
08.03.24 08:03
London (www.aktiencheck.de, Anzeige)
![Okta Raises EPS Forecasts Despite High Profile Security Breaches: https://www.marketbeat.com/logos/articles/med_20240303140829_charts-okta.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBekJOYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d9e26931f52240e72fc434a01c5ef93d588cc1de/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240303140829_charts-okta.jpg?locale=de)
Okta Raises EPS Forecasts Despite High Profile Security Breaches
Okta Inc. (NASDAQ: OKTA) is a cybersecurity company that specializes in identity and access management (IAM) solutions. The computer and technology sector firm helps companies protect against
![Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. 661% Biotech Hot Stock nach 15.973% mit Biotech ($BNTX): https://www.irw-press.at/prcom/images/messages/2024/73865/AC-070324.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0ZNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--61ad870031d1bc5180acc09f65e65849b21d8ab0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-070324.001.png?locale=de)
Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. 661% Biotech Hot Stock nach 15.973% mit Biotech ($BNTX)
Eilt: Durchbruch in der Krebsforschung - Hautkrebs vollständig geheilt. 661% Biotech Hot Stock nach 134.452% mit Biogen
07.03.24 08:02
London (www.aktiencheck.de , Anzeige)
![CrowdStrikes’s Stock Price Will Hit $500 Soon: https://www.marketbeat.com/logos/articles/med_20240306080204_chart-crwd-362024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMGRNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bc297af6fc3f86023f626e18798a889b24bf041c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240306080204_chart-crwd-362024ver001.png?locale=de)
CrowdStrikes’s Stock Price Will Hit $500 Soon
The price action in CrowdStrike (NASDAQ: CRWD) stock is up 25% following the Q4 release and 2024 guidance, but the rally is not over yet. The results and outlook confirm the company’s momentum is
![Higher Highs are Fast Approaching for AMD Stock: https://www.marketbeat.com/logos/articles/med_20240306080319_higher-highs-are-fast-approaching-for-amd-stock.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMGhNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3cf17621472bb19290a7057b4a1bf1ef939f5792/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240306080319_higher-highs-are-fast-approaching-for-amd-stock.jpg?locale=de)
Higher Highs are Fast Approaching for AMD Stock
While Advanced Micro Devices (NASDAQ: AMD) might not always steal the spotlight like its competitor Nvidia (NASDAQ: NVDA), investors in this global semiconductor powerhouse have plenty to cheer
![Bargain Alert: Alphabet Stock Won’t Be This Cheap For Long: https://www.marketbeat.com/logos/articles/med_20240305150213_bargain-alert-alphabet-stock-wont-be-this-cheap-fo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeVpNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c87df828a18985ceab30829d152240e38c047098/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240305150213_bargain-alert-alphabet-stock-wont-be-this-cheap-fo.jpg?locale=de)
Bargain Alert: Alphabet Stock Won’t Be This Cheap For Long
While it managed to tag a fresh all-time high in January, shares of Alphabet Inc (NASDAQ: GOOGL) have been trading softly in the weeks since. It’s a usual divergence from the broader market, given
![Institutions are Buying Broadcom Stock, a 30% Discount to Nvidia: https://www.marketbeat.com/logos/articles/med_20240305135240_institutions-are-buying-broadcom-stock-a-30-discou.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2hMYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d7ccc8fccdf7d86a3a90dbe352ab9c4cf103cbef/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240305135240_institutions-are-buying-broadcom-stock-a-30-discou.jpg?locale=de)
Institutions are Buying Broadcom Stock, a 30% Discount to Nvidia
Everyone in the market is excited about the new breakouts in the technology stock space, with a particular focus on names like NVIDIA (NASDAQ: NVDA), termed the king of the pack. After breaking
![Apple Scraps EV Plans: Here’s What’s Next, Lower Prices: https://www.marketbeat.com/logos/articles/med_20240305125731_chart-aapl-352024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2RMYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0c012e408a32c4329d6618727ccb895e4fe51496/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240305125731_chart-aapl-352024ver001.png?locale=de)
Apple Scraps EV Plans: Here’s What’s Next, Lower Prices
Unsurprisingly, Apple (NASDAQ: AAPL) scrapped its plans to build an electric vehicle. After ten years of effort, the goal to launch a 100% autonomous vehicle in 2024 failed to produce even a
![Biotech Hot Stock 2024: Erstklassige Studienergebnisse - Hautkrebs vollständig geheilt. Diese Biotech-Aktie jetzt kaufen nach 15.973% mit Biotech ($BNTX): https://www.irw-press.at/prcom/images/messages/2024/73854/AC_Vidac_060324.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHhMYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3b875ab0589d7a57169a2ae0eb0af9988c8df4a7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_Vidac_060324.001.png?locale=de)
Biotech Hot Stock 2024: Erstklassige Studienergebnisse - Hautkrebs vollständig geheilt. Diese Biotech-Aktie jetzt kaufen nach 15.973% mit Biotech ($BNTX)
Biotech Hot Stock 2024: Erstklassige Studienergebnisse - Hautkrebs vollständig geheilt. Diese Biotech-Aktie jetzt kaufen
06.03.24 08:02
London (www.aktiencheck.de, Anzeige)
![Eilt: 95% weniger Medikamente - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73839/acresearch050324.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOUpKYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f452ffdaf162d2d370a06e62cf962a216726f393/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/acresearch050324.001.png?locale=de)
Eilt: 95% weniger Medikamente - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: 95% weniger Medikamente - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Hot Stock nach 9.290% mit Novo-Nordisk
05.03.24
London (www.aktiencheck.de, Anzeige)
![Eilt: 100 mal wirksamer gegen Krebs - Großinvestoren unmittelbar vor Einstieg. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73815/AC-040324.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd3BJYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d416f4980721a69c901db98988f78388926f1739/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-040324.001.png?locale=de)
Eilt: 100 mal wirksamer gegen Krebs - Großinvestoren unmittelbar vor Einstieg. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: 100 mal wirksamer gegen Krebs - Großinvestoren unmittelbar vor Einstieg. Neuer 503% Biotech Hot Stock nach 15.973%
04.03.24 08:02
London (www.aktiencheck.de , Anzeige)
![Nvidia's Soaring Success: Too Late to Buy?: https://www.marketbeat.com/logos/articles/med_20240301081214_nvidias-soaring-success-too-late-to-buy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2hHYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--db3a5601279e5a36cf33a554cc5235e6a00ee347/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240301081214_nvidias-soaring-success-too-late-to-buy.jpg?locale=de)
Nvidia's Soaring Success: Too Late to Buy?
At the forefront of the market surge stands Nvidia (NASDAQ: NVDA), continuing its meteoric rise into the new year. Last year’s champion stock has wasted no time in extending its winning streak,
![3 Stocks Showing Constructive Pullbacks with Indexes at New Highs: https://www.marketbeat.com/logos/articles/med_20240301101105_3-stocks-showing-constructive-pullbacks-with-index.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNVZHYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5d99db235f8b691343da05c3c526a5b603018e95/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240301101105_3-stocks-showing-constructive-pullbacks-with-index.jpg?locale=de)
3 Stocks Showing Constructive Pullbacks with Indexes at New Highs
One of the most exciting things for an investor or trader is to look at tier account statement, or at the charts of what they own, and see a stock like Nvidia Corp. (NASDAQ: NVDA) or even the
![Zscaler Stock Price Plunges: Buy the Dip Candidate: https://www.marketbeat.com/logos/articles/med_20240301074904_chart-zs-312024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2RHYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fb3be84eab4c627799c56d819e466c81d8bd5fe1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240301074904_chart-zs-312024ver001.png?locale=de)
Zscaler Stock Price Plunges: Buy the Dip Candidate
Zscaler (NASDAQ: ZS) had a robust Q2 and raised its guidance, but it was not enough to lift the market. The results and valuation suggest the stock is priced to perfection following the
![Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73797/AC-010324.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeDFHYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--11c6d13c0e743c29bffd8f6632db47a816088aa6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-010324.001.png?locale=de)
Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 503% Biotech Aktientip nach 134.452% mit Biogen
01.03.24 08:03
London (www.aktiencheck.de, Anzeige)
![Salesforce.com Stock Will Set a New High This Year: https://www.marketbeat.com/logos/articles/med_20240229093245_chart-crm-2292024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXRGYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--11f791015560dbed45bda5af8b2826cecaa30d59/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240229093245_chart-crm-2292024ver001.png?locale=de)
Salesforce.com Stock Will Set a New High This Year
Salesforce.com’s (NYSE: CRM) stock price is having trouble with traction following the Q4 results and guidance, but a massive correction is not expected for this tech stock. The results did not